Sequential Action of Two Flavoenzymes, PgaE and PgaM, in Angucycline Biosynthesis: Chemoenzymatic Synthesis of Gaudimycin C  by Kallio, Pauli et al.
Chemistry & Biology
ArticleSequential Action of Two Flavoenzymes, PgaE and
PgaM, in Angucycline Biosynthesis: Chemoenzymatic
Synthesis of Gaudimycin C
Pauli Kallio,1,3 Zhanliang Liu,1,2,3 Pekka Ma¨ntsa¨la¨,1 Jarmo Niemi,1 and Mikko Metsa¨-Ketela¨1,*
1Department of Biochemistry and Food Chemistry, University of Turku, FIN-20014 Turku, Finland
2Department of Plant Pathology, Agricultural University of Hebei, Baoding 071001, China
3These authors contributed equally to this work.
*Correspondence: mikko.mk@gmail.com
DOI 10.1016/j.chembiol.2007.12.011SUMMARY
Tailoring steps in aromatic polyketide antibiotic bio-
synthesis are an important source of structural diver-
sity and, consequently, an intriguing focal point for
enzymological studies. PgaE and PgaM from Strep-
tomyces sp. PGA64 are representatives of flavoen-
zymes catalyzing early post-PKS reactions in angu-
cycline biosynthesis. This in vitro study illustrates
that the chemoenzymatic conversion of UWM6
into the metabolite, gaudimycin C, requires multiple
closely coupled reactions to prevent intermediate
degradation. The NMR structure of gaudimycin C
confirms that the reaction cascade involves C12-
and C12b-hydroxylation, C2,3-dehydration, and
stereospecific ketoreduction at C6. Enzymatic 18O
incorporation studies verify that the oxygens at C12
and C12b derive from O2 and H2O, respectively.
The results indicate that PgaM deviates mechanisti-
cally from flavoprotein monooxygenases, and sug-
gest an alternative catalytic mechanism involving a
quinone methide intermediate.
INTRODUCTION
Aromatic polyketides are complex natural compounds well es-
tablished for their biological activities and applications in medi-
cine (Newman et al., 2000). They are produced by a number of
different organisms, but especially Streptomyces bacteria have
been a rich source of natural product diversity (Bentley et al.,
2002; Omura et al., 2001). Angucyclines comprise a distinct
group of aromatic polyketides (Rohr and Thiericke, 1992), which
are characterized by the angular shape of the polyaromatic tet-
racyclic ring that differentiates these compounds from the
closely related anthracyclines (Strohl et al., 1997; Niemi et al.,
2002) and tetracyclines (Hunter, 2002). Typical examples of an-
gucyclines are urdamycin (Drautz et al., 1986) and landomycin
(Henkel et al., 1990), products of the two most extensively
studied biosynthetic pathways. Angucyclines have been shown
to exhibit a variety of activities of medical interest (Rohr and
Thiericke, 1992) including antitumor (Korynevska et al., 2007;
Antal et al., 2005) and antibacterial activities (Antal et al., 2005;Chemistry & Biology 15Abdelfattah et al., 2003), as well as platelet aggregation inhibition
(Omura et al., 1988; Kawashima et al., 1989). Angucyclines were
first discovered in 1965 (Dann et al., 1965), but still only a few
hundred structures have been described. Recent genetic
screening studies have indicated that angucycline gene clusters
are much more abundant than expected based on traditional
cultivation methods (Metsa¨-Ketela¨ et al., 2002), which suggests
that many potentially important angucyclines are yet to be dis-
covered. The pga and cab systems discussed in this article are
examples of such cryptic gene clusters, and they were initially
cloned to increase the biosynthetic potential for combinatorial
biosynthesis applications (Palmu et al., 2007).
The carbon skeleton of angucyclines is based on the four-
ringed benz[a]anthracene system (Rohr and Thiericke, 1992).
Biosynthetically, they belong to the family of aromatic type II
polyketides (Hopwood, 1997; Hertweck et al., 2007), whichmeans
that the initial steps in the biosynthesis resemble those of bacte-
rial type II fatty acid synthesis. The biosynthesis begins by the it-
erative action of the minimal PKS complex, which consists of
a ketosynthase/chain length factor (KSa/CLF or KSa/KSb) heter-
odimer and an acyl carrier protein. The complex polymerizes 10
acetate building blocks to form a highly reactive 20 carbon poly-
ketide chain, which is subsequently folded in a controlled man-
ner into the first stable intermediate, UWM6 (1, Figure 1) by ketor-
eductases, aromatases, and cyclases (Kulowski et al., 1999;
Metsa¨-Ketela¨ et al., 2003). After this point, different angucycline
pathways diverge through the action of numerous tailoring or
post-PKS enzymes. These biosynthetic tailoring steps are im-
portant for generation of the vast chemical diversity of the com-
pounds (Rix et al., 2002) and, consequently, are of special inter-
est for genetic and enzymological studies.
Several in vivo studies have suggested that early angucycline
post-PKS tailoring steps are commonly accompanied by further
bioconversion events in Streptomyces. The reactions have been
shown to deviate from the pathways to shunt products (Palmu
et al., 2007; Rix et al., 2003, 2005; Mayer et al., 2005) and to re-
sult in unexpected alterations in the compounds produced
(Palmu et al., 2007). In parallel, possible involvement of nonenzy-
matic reactions (Palmu et al., 2007; Metsa¨-Ketela¨ et al., 2003),
unusual bifunctionality, and atypical enzymology (Mayer et al.,
2005; Chen et al., 2005) have been associated with these biosyn-
thetic steps. As a result, separation of the individual catalytic
events from nonspecific spontaneous or endogenous reactions
has been challenging, and has complicated the functional, 157–166, February 2008 ª2008 Elsevier Ltd All rights reserved 157
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enzymology of angucycline early post-PKS tailoring reactions
are yet to be comprehensively described in vitro.
The most common enzymes associated with these reactions
are homologous to flavoprotein monooxygenases and short
chain alcohol dehydrogenase/reductases (SDRs). PgaE (Koski-
niemi et al., 2007) and PgaM (Kallio et al., 2007) covered in this
article are representatives of such enzymes. They originate
from the silent angucycline gene cluster, pga, isolated from
Streptomyces sp. PGA64, which is not active under laboratory
conditions (Metsa¨-Ketela¨ et al., 2004). PgaE is homologous to
the well-characterized flavoenzyme, p-hydroxybenzoate hy-
droxylase (Schreuder et al., 1989), and orthologous genes are
found in most angucycline gene clusters (Palmu et al., 2007). Ac-
cording to heterologous expression studies, it uses 1, the first
stable intermediate of the pathway, as a substrate, and has
been associated with the C12-hydroxylation reaction. However,
the in vivo reaction of PgaE was shown to be accompanied by
additional chemical changes resulting in the formation of a puta-
tive shunt product, rabelomycin (2, Figure 1) (Palmu et al., 2007).
PgaM is a two-domain flavoprotein that contains an N-terminal
domain homologous to FAD-dependent monooxygenases,
which is fused to a domain homologous to SDRs via a short linker
region (Kallio et al., 2007;Metsa¨-Ketela¨ et al., 2004). The oxygen-
ase domain of PgaM shares sequence similarity with PgaE (50%
amino acid sequence identity) and p-hydroxybenzoate hydroxy-
lase, which designates it as a member of subclass A of flavopro-
Figure 1. Structures and Numbering of Angucycline Metabolites
(A) The substrate of PgaE, UWM6 (1).
(B) The observed in vivo product of PgaE, rabelomycin (2).
(C) The in vivo product of PgaE/PgaM, gaudimycin A (3).
(D) The in vivo product of the related cab pathway, gaudimycin B (4).
(E) The in vitro product of PgaE/PgaM, gaudimycin C (5).158 Chemistry & Biology 15, 157–166, February 2008 ª2008 Elsevietein monooxygenases based on sequence information (van Ber-
kel et al., 2006). The SDR domain of PgaM has been shown to
catalyze 2,3-dehydration, whereas the N-terminal oxygenase
domain has been associated with an enzymatically unusual
C12b-hydroxylation (Palmu et al., 2007). Curiously, the in vivo
product of the PgaM reaction, gaudimycin A (3, Figure 1), had
lost the C6-hydroxyl group, which was inconsistent with the ex-
pected functions of the tailoring genes used in the study (Palmu
et al., 2007). Genes homologous to pgaM are infrequently en-
countered in Streptomyces genomes and not found outside an-
gucycline biosynthesis, but the functions of homologous genes
from urdamycin (Rix et al., 2003) and landomycin (Zhu et al.,
2005) pathways have been elucidated.
The aim of this study was to gain insight into the early, com-
mon tailoring steps in angucycline biosynthesis with PgaE and
PgaM as model enzymes. Specifically, one of the initiatives
was to investigate the enzymatically enigmatic C12b-hydroxyl-
ation reaction, which is a common step in the biosynthetic path-
ways of many angucyclines. Here we provide direct evidence
that the angucycline intermediates involved are highly reactive,
which causes consecutive catalytic steps to be dependent on ef-
ficient enzyme coupling, and explains many unexpected events
observed in vivo. We also present the structure of a novel poly-
ketide, gaudimycin C (5, Figure 1) formed in chemoenzymatic
synthesis by PgaE and PgaM. The structure allowed us to de-
duce each step in the conversion, and confirmed the loss of
the C6-hydroxyl group of 3 to result from endogenous reactions
catalyzed by the host strain, Streptomyces lividans TK24. Fur-
thermore, 18O isotope incorporation studies showed that the ox-
ygen incorporated by PgaM derives from H2O. This implies that
the oxygenase domain of PgaM is not a member of flavoprotein
monooxygenases, despite sequence similarity, but catalyzes
a novel hydroxylation reaction, possibly through a quinone me-
thide (QM) intermediate.
RESULTS
Production of Proteins and Substrates
All proteins were produced and purified as N-terminal His-tag fu-
sions, PgaE and PgaMox, which is a deletion mutant containing
the N-terminal oxygenase domain of PgaM alone in Escherichia
coli TOP10, and PgaM in S. lividans TK24. The soluble yield of
PgaE expression was over 40 mg/l culture medium. Color of
the final preparate (5 mg/ml) was intense yellow, consistent
with the presence of FAD. The gene, pgaM, contains an unusual
genetic organization of two overlapping reading frames, where
the SDR reductase domain is produced as the C-terminal part
of PgaM, but also as an independently translated reductase sub-
unit, PgaMred, due to an internal start codon (Kallio et al., 2007).
The two different isoforms were produced and copurified to-
gether in one nickel affinity chromatography step. These were
seen in SDS-PAGE chromatography as separate bands migrat-
ing at 85 kDa and 27 kDa, which account for full-length, two-do-
main PgaM and independently encoded reductase PgaMred, re-
spectively. The total purification yield was up to 2 mg/l culture,
and the final preparate was light yellow in color, consistent
with the binding motif for FAD found in sequence of the oxygen-
ase subunit (Metsa¨-Ketela¨ et al., 2004). The purification yield of
PgaMox was over 8 mg/l culture media, and again the proteinr Ltd All rights reserved
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enzymatic studies was produced and purified, yielding 2 mg/l
culture media. Color of 1methanol stock used for activity assays
(0.1 mg/ml) was clear, bright yellow. Rabelomycin (2) was
extracted and purified as a by-product of production of 1.
PgaE Reaction with UWM6 Yields an Unstable Product
PgaE was shown to consume 1 as a substrate in the presence of
molecular oxygen and NADPH, as detected spectrophotometri-
cally as a linear decrease of absorption at the substrate maxi-
mum of 406 nm (Figure 2A). The loss of yellow color of 1 by
PgaE was accompanied by the disappearance of the corre-
sponding signal in HPLC (Figure 2B), but instead of yielding a sin-
gle product, the reaction resulted in the appearance of several
minor peaks (Figure 3A). The compounds detected exhibited in-
creased hydrophilicity and absorption maxima below the visible
wavelength range, and no plausible PgaE product candidates
could be observed. According to LC-MS analysis, molecular
ion mass of the main fragment with absorption maximum at
367 nm (Figure 3A) was only 325 amu, 18 amu less than that of
1. The compounds reacted further in extended incubation of
the reaction mixture after depletion of 1. This was observed as
gradual reduction of HPLC signal intensities together with a shift
in the overall elution profile toward the void volume (Figures 3B–
3C). In the absence of PgaE, 1 remained stable and did not show
any signs of spontaneous conversion or degradation (Figure 2C).
PgaM Converts the PgaE Product
into a Novel Compound
PgaM did not have any activity toward 1 under equivalent reac-
tion conditions. Instead, a coupled reaction with both PgaE and
PgaM resulted in the appearance of a new peak observed in
HPLC UV-Vis (Figure 4A). The product had an absorption maxi-
mum at 428 nm, and, based on LC-MS analysis, a mass (356
m/z) 14 amu higher than that of 1. The mass was 16 amu higher
in comparison with the equivalent in vivo product, 3, and the
same as that of the in vivo product of the related cab pathway,
gaudimycin B (4, Figure 1), produced in S. lividans TK24 (Palmu
et al., 2007). RP-HPLC retention times of the compounds were
clearly distinct and, accordingly, the product was named gaudi-
mycin C (5).
The products detected in the PgaE reaction were shown not to
be intermediates in the pathway, as they failed to produce 5
when isolated and incubated with PgaM (Figure 4B). In essence,
pathway intermediates were not detected at any stage of the re-
action cascade between the initial substrate 1 and 5. A common
shunt product, 2, detected in studies with related angucycline
post-PKS enzymes (Rix et al., 2003; Ku¨nzel et al., 1999) and
the pga pathway in vivo (Palmu et al., 2007), was not observed
as a by-product in any of the reactions, nor was it accepted as
a substrate by either of the enzymes. The deletion mutant, Pga-
Mox, did not express any activity when coupled to the PgaE re-
action, indicating that the reductase domain of PgaM is required
to act before the oxygenase domain.
Gaudimycin C Formation Requires Uninterrupted
Sequence of Reactions
In the optimized reaction conditions, with a 3-fold molar excess
of PgaM over PgaE, conversion of 1 to 5 was quantitativeChemistry & Biology 15,(Figure 4A). Failure to couple the successive biosynthetic steps
induced intermediate degradation and resulted in the appear-
ance of PgaE shunt products. First, the simultaneous presence
of the two enzymes was a strict requirement for formation of 5,
and delayed introduction of PgaM during or at the end of
the PgaE reaction caused a proportional reduction in the yield
(Figures 4C–4D). Second, deviation from the optimal molar ratio
between the enzymes by addition of an excess of PgaE had
a corresponding effect (Figure 4E). Third, separation of PgaE
and PgaM into compartments by using a semipermeable mem-
brane also prevented formation of 5 (Figure 4F), although 1
and the minor products of the PgaE reaction were shown to
diffuse freely through the membrane and to occupy both com-
partments. Despite the apparent need for close functional inter-
action between PgaE and PgaM, no signs of noncovalent com-
plex formation could be detected in either glutaraldehyde
cross-linking experiments or analytical HPLC gel filtration
studies.
Figure 2. Monitoring of the PgaE Reaction in the Presence of 1,
NADPH, and Molecular Oxygen
(A) Reaction followed spectrophotometrically at the substrate absorptionmax-
imum of 406 nm.
(B) HPLC analysis of extracted reaction products demonstrate that no com-
pounds absorb at the Vis range.
(C) In the absence of PgaE, the substrate remains intact.157–166, February 2008 ª2008 Elsevier Ltd All rights reserved 159
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Product in Aqueous Solution
HPLC analysis of parallel reactions followed at
three different time points after consumption of 1.
(A) Analysis of products extracted at the end of the
reaction. The main fragment has an absorbtion
maximum at 367 nm and molecular mass 324
g/mol.
(B) At 15min after the depletion of 1, themain peak
has decreased in size along with an increase of
peaks with shorter retention times.
(C) After 30 min, the main peak has disappeared
and the majority of the compounds detected elute
within the first few minutes of the run.AddedOxygens in Gaudimycin CDerive fromO2 andH2O
Consumption of 1 by PgaE was inhibited when air was removed
from the reactionmixture, and proceeded only after aerobic con-
ditions were restored, as seen spectrophotometrically in a Thun-
berg cuvette. A parallel experiment to examine PgaM oxygen
dependence could not be devised due to the lack of a stable
substrate. A coupled reaction with both enzymes under 18O2 at-
mosphere resulted in a 2 amu increase of all major fragmentation
products detected by LC-MS in comparison with a reaction
carried out in normal air (Table 1), corresponding to the incor-
poration of a single 18O atom in the first aerobic step. Parallel ex-
periments in 18O-labeled water also resulted in a 2 amu shift in
LC-MS peaks, demonstrating that another oxygen is introduced
into 5 from H2O (Table 1).
NMR Structural Analysis of Gaudimycin C
Preparative scale chemoenzymatic conversion of 1 by PgaE and
PgaM yielded sufficient quantities of purified 5 for full structural
analysis by NMR. The 1H and 13C NMR spectra (Table 2) of 5
were highly similar to those of 4, which is the in vivo intermediate
from the related cab pathway (Palmu et al., 2007). The COSY,
HSQC, and HMBC correlations (see Figure S1 in the Supple-
mental Data available with this article online) confirmed that
the benz[a]anthracene carbon skeleton and the position of hy-
droxyl groups at carbons 4a (d 3.66), 6 (d 4.25), 8 (d 12.01)
and 12b (d 7.11) were the same in 4 and 5. Differences were fi-
nally seen in stereochemistry at position 6 by 1D NOE experi-
ments (Figure S1), which, in 5, permitted the observation of
NOEs between the hydroxyl proton at carbon 4a and the hy-
droxyl protons at positions 6 and 12b. In 4, similar experiments
revealed NOEs between the hydroxyl proton at position 4a and
H-6 and the hydroxyl proton at carbon 12b (Palmu et al., 2007).
These results proved 5 to be 6-hydroxy gaudimycin A and a
diastereomer of 4.
DISCUSSION
Several in vivo studies have indicated that reaction intermedi-
ates in early post-PKS tailoring steps of various angucycline bio-
synthetic pathways exhibit unusually high inherent reactivity.160 Chemistry & Biology 15, 157–166, February 2008 ª2008 ElsevieThis forestalls direct approaches to analyze the individual cata-
lytic events, as separation of consecutive steps readily induces
shunt product formation through either nonenzymatic conver-
sion and/or endogenous modification by the host (Palmu et al.,
2007; Rix et al., 2003, 2005). Due to the requirement for simulta-
neous presence of all enzyme components to maintain the bio-
synthesis on the correct pathway, related reaction sequences
have been referred to as ‘‘biosynthetic black boxes,’’ and have
been associated with the formation of putative post-PKS oligo-
meric protein complexes (Rix et al., 2005; Kharel et al., 2007).
Here we report, to our knowledge, the first in vitro study of an
isolated oxygenation cascade, providing biochemical insight
into the order and nature of individual catalytic steps, with angu-
cycline tailoring flavoproteins PgaE and PgaM from Streptomy-
ces sp. PGA64 as model enzymes. PgaE and PgaM were shown
to catalyze an array of reactions, converting the first stable inter-
mediate of the pathway, 1, into a novel metabolite, 5. The results
demonstrate to our knowledge, for the first time directly, that the
early oxygenation steps in certain angucycline pathways are
highly dependent on close functional coupling, and must pro-
ceed in an uninterrupted sequence to avoid intermediate break-
down. Although this may imply noncovalent association be-
tween the enzymes as suggested previously (Rix et al., 2005;
Fedoryshyn et al., 2007), direct, size-based analytical methods
did not show any evidence of complex formation. The NMR
structure of 5 revealed the PgaE/PgaM reaction cascade to in-
volve (1) hydroxylation of 1 at position C12 followed by C7,12
p-quinone formation, (2) dehydration between C2 and C3, (3) hy-
droxylation of C12b, and (4) stereospecific C6 ketoreduction.
Together with 18O incorporation studies, the results allowed us
to postulate specific activities for each putative functional com-
ponent involved.
PgaE Functions as UWM6 12-Hydroxylase
PgaE catalyzes the first step of the PgaE/PgaM reaction se-
quence with 1 as a substrate in the presence of air and NADPH.
Demonstrated by the 18O2 isotope incorporation studies and ox-
ygen dependence, PgaE introduces a single oxygen atom from
O2 into the substrate. Comparison of the structure of 5 with
that of 1 revealed positions C12 and C12b as the two possibler Ltd All rights reserved
Chemistry & Biology
Chemoenzymatic Synthesis of Gaudimycin Ctargets for PgaE-hydroxylation. This assessment, together with
the observations that the in vivo reaction yields 2 (Palmu et al.,
2007), which is not oxygenated at C12b, and that hydrogen per-
oxide is not formed in the reaction (Koskiniemi et al., 2007) verify
PgaE as a 1C12-hydroxylase (Figure 5). This is in agreement with
the reported function of a close sequence homolog, UrdE (76%
aa identity with PgaE), responsible for the corresponding reac-
tion in urdamycin biosynthesis (Faust et al., 2000). The hydroxyl-
ation reaction yields a 7,12-dihydroquinone intermediate, which
is conceivably readily oxidized to form the p-quinone structure
observed in 5. The oxidation may occur nonenzymatically, but,
in the case of the pga system, requires enzyme stabilization to
prevent further reactions that lead to a degradation pathway in
aqueous solution.
The PgaM Reductase Domain Catalyzes
2,3-Dehydration
The number of observed chemical changes in 5 confirmed the in-
volvement of PgaM in multiple catalytic events, as postulated by
the presence of two putative functional domains. One of these
functions is 2,3-dehydratase activity (Figure 5), detected as the
loss of the 3-hydroxyl group in both 5 and 3 (Palmu et al.,
2007). In landomycin biosynthesis, 2,3-dehydration has been re-
ported as one of the multiple in vivo functions of LanV (Mayer
et al., 2005), which is homologous to the SDR domain of
Figure 4. Comparison of Gaudimycin C, 5,
Formation in Coupled PgaE and PgaM
Reactions
Compound 5 is detected at 428 nm (solid line),
whereas degradation products of the PgaE reac-
tion are monitored at 230 nm (dashed line, relative
scale).
(A) In an efficiently coupled reaction, PgaE and
PgaM convert 1 to 5 in the presence of NADPH
and molecular oxygen.
(B) Incubation of isolated products of the PgaE
reaction with PgaM does not yield 5.
(C) Addition of PgaM in a coupled reaction after
over 50% of 1 has been consumed by PgaE
results in a decreased yield of 5, proportional to
the remaining amount of substrate.
(D) Addition of PgaM at the end of the PgaE reac-
tion produces a barely detectible amount of 5.
(E) Decrease in formation of 5 can also be seen
upon 100-fold increase of the relative amount of
PgaE.
(F) Separation of the PgaE and PgaM reactions
with a semipermeable membrane completely
inhibits formation of 5, although 1 and shunt
products of the PgaE reaction pass through the
membrane.
PgaM. Members of this SDR family com-
monly catalyze dehydrogenation reac-
tions (Jo¨rnvall et al., 1995), but some
have been shown to act as dehydratases
(Allard et al., 2002). The removal of the
C3-hydroxyl group appears to be the first
reaction catalyzed by PgaM, as the iso-
lated oxygenase domain failed to exhibit any activity when
coupled to the PgaE reaction in vitro.
The Oxygenase Domain of PgaM Is Responsible
for 12b-Hydroxylation
The structure of 5 together with the deduced function of PgaE
confirms that PgaM is also responsible for hydroxylation of posi-
tion C12b. This is in agreement with the in vivo function assigned
for the homologous gene product of urdM in urdamycin biosyn-
thesis (Faust et al., 2000). Interestingly, there is an explicit differ-
ence between these reactions, as the C12b oxygen in urdamycin
has been shown to derive from molecular oxygen (Udvarnoki
et al., 1992), whereas, in the case of 5, it clearly originates from
water. This has direct mechanistic implications, which are dis-
cussed in detail in the final section of the Discussion.
The Loss of the 6-Hydroxyl Group In Vivo
and 6-Ketoreduction In Vitro
PgaM is affiliated with yet another reaction, C6 ketoreduction of
the angucyclic substrate, deduced by the presence of a hydroxyl
group at this position in 5. The reaction appears to be stereospe-
cific, as the opposite orientation of the C6-OH groups is the only
difference between this product and 4, the corresponding in vivo
product of the related cab pathway. This stereochemical differ-
ence can also be seen indirectly from the structure of the pga
in vivo product, 3. It has lost the C6-hydroxyl group still retainedChemistry & Biology 15, 157–166, February 2008 ª2008 Elsevier Ltd All rights reserved 161
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sults from stereoselective endogenous modification by the
host strain, S. lividans TK24. The pga product appears to be ac-
cepted as a substrate for the endogenous reactions, while the
opposite stereoisomer of the cab pathway is left intact. Impor-
tantly, this confirms the C6 ketoreduction step to be enantiose-
lective also in physiological surroundings, and not merely an
effect caused by the reaction conditions in vitro. It is also note-
worthy that all C12b-hydroxylated 12,7-quinone angucyclines
appear to have undergone the C6 ketoreduction step, which
may imply some mechanistic interconnection between the two
catalytic events.
Mechanisms Involved with 12b-Hydroxylation
and 6-Ketoreduction
Flavoprotein monooxygenases homologous to the oxygenase
domain of PgaM exclusively use molecular oxygen as a sub-
strate, but certain reactions may proceed through an H2O-as-
sisted heterocycle ring cleavage to incorporate a water-derived
oxygen into the product. These reactions, however, appear
mechanistically incompatible with the PgaM-catalyzed steps
in the biosynthesis of 5. For example a Baeyer-Villiger reaction
described for several types of flavoenzymes (Iwaki et al., 2006;
Fraaije et al., 2005; Jones et al., 1993) may involve a step of lac-
tone ring opening to introduce oxygen from water, but fails to
explain the regeneration of the six-membered carbon ring A.
The free carboxylic acid generated in the cleavage is not chem-
ically a suitable substrate for known condensation mecha-
nisms, such as aldol or Claisen. If the Baeyer-Villiger reaction
proceeded via the rearrangement reaction proposed for urda-
mycin C12b monooxygenation (Rix et al., 2003), the incorpo-
rated oxygen would originate from O2 and not from water, as
observed here. Another candidate, an epoxidase reaction fol-
lowed by opening of the oxirane ring by H2O, has been dis-
cussed in the context of tetracenomycin 4a-hydroxylation (Ra-
fanan et al., 2000) and urdamycin 12b-hydroxylation (Udvarnoki
et al., 1992). This would, however, require the formation of a
4a/12b epoxysemiquinone structure, which does not seem fea-
sible with the C4a tertiary carbon of the substrate being already
hydroxylated and incapable of further oxidation. Other flavo-
protein mechanisms, such as the aromatic monooxygenation
Table 1. Analysis of Oxygen Incorporation in Coupled PgaE and
PgaM Reactions Carried Out in 18O2 and H2
18O by LC-MS
LC-MS
Fragment
Peak Intensity
(18O/16O) In Air
In 18O2
(100%) In H2O
In H2
18O
(58%)
M + Na 381/379 0.16 12.97 0.06 2.66
M + 1 359/357 0.07 8.42 0.04 2.24
M  H2O 341/339 0.06 12.86 0.09 2.07
M  2H2O 323/321 0.05 2.05 0.09 2.46
M  61 Da 295/293 0.08 3.13 0.13 2.27
The data demonstrate that one of the incorporated oxygens in 5 derives
from molecular oxygen and the other from water. Efficiency of oxygen
isotope incorporation is calculated as the 18O:16O ratio in reaction prod-
uct fragments in LC-MS (rounded down for consistency). Fluctuations of
values in the 18O2 column are due to low
16O-derived signals, which may
fall between integration points.162 Chemistry & Biology 15, 157–166, February 2008 ª2008 Elseviecatalyzed by the well-characterized p-hydroxybenzoate hy-
droxylase (Schreuder et al., 1989), cannot account for the
H2O-derived oxygen. In addition, none of the flavoprotein
monooxygenase mechanisms explain the stereospecific C6
ketoreduction reaction, which occurs during gaudimycin C
formation.
Intriguingly, a distinct group of FAD-dependent flavoproteins
has been found to catalyze a sequence of reactions that closely
resembles the C12b-hydroxylation and C6 ketoreduction steps
in the biosynthesis of 5. These enzymes hydroxylate various ar-
omatic substrates in degradation of toxic phenol/benzo com-
pounds (Cunane et al., 2000; Fraaije and van Berkel, 1997; Hop-
per andCottrell, 2003), and bear no sequence similarity to PgaM.
The reactions differ mechanistically from those of flavoprotein
monooxygenases, and use oxidized flavin to generate a highly
reactive QM intermediate, followed by incorporation of oxygen
derived from water (Hopper and Cottrell, 2003; van den Heuvel
et al., 2000). Ultimately, the reaction results in an intramolecular
redox hydration involving parallel hydroxylation and stereospe-
cific keto group reduction, as observed for 5. Although the
PgaM flavin redox cycle is presently unclear, the central concept
of the catalytic mechanism, the redox conversion to form a highly
polarized QM structure, has been described for for anthracy-
clines (Freccero, 2004), compounds closely related to angucy-
clines.
Table 2. 1H and 13C NMR Data for Gaudimycin C, 5, in CHCl3-d1
Position 1H NMR 13C NMR
1 — 196.3
2 5.92 (s) 122.4
3 — 161.2
4 2.93 (d) 43.1
2.45 (d) —
4a-OH 3.66 (s) 74.0
5 2.30 (dd) 34.7
2.10 (dd) —
6 4.94 (m) 61.0
6-OH 4.25 (d) —
6a — 144.1
7 — 188.5
7a — 114.6
8 — 161.4
8-OH 12.01 (s) —
9 7.35 (d) 125.7
10 7.70 (t) 137.0
11 7.73 (d) 120.5
11a — 131.5
12 — 188.3
12a — 138.4
12b-OH 7.11 (s) 78.4
13-CH3 2.06 (s) 24.8
Assignments were made by using COSY, HSQC, and HMBC difference
measurements. Carbons 7 and 12 were assigned based on the chemical
shifts of the corresponding carbons in the related gaudimycins A and B
(Palmu et al., 2007).r Ltd All rights reserved
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In the first step, PgaE catalyzes hydroxylation of UWM6 at position 12, which is followed by quinone formation. The first reaction of PgaM is catalyzed by the SDR
domain (PgaMred), resulting in 2,3-dehydration. Finally, the oxygenase domain of PgaM (PgaMox) catalyzes C12b-hydroxylation and C6 ketoreduction by the
QM mechanism. This is initiated by enzyme-induced tautomerization of the substrate to form a highly polarized o-QM. The conjugated intermediate is readily
hydrated to 5 in an intramolecular redox reaction involving enzyme-stabilized nucleophilic addition of water at C12b and reduction of C6.All chemical changes associated with the PgaM oxygenase
domain in formation of 5 can be explained by the model pre-
sented in Figure 5. The reaction initiates by substrate activation
in an enzyme-induced tautomerization to generate a highly con-
jugated angucycline o-QM intermediate, a structure analogous
to the anthracycline QM species (Freccero, 2004). The keto
group adjacent to the reacting C12b facilitates the a-proton re-
moval to yield this tautomer. Once formed, the QM intermediate
is expected to readily undergo hydration in the presence of wa-
ter, in this case by stereospecific nucleophilic attack of an en-
zyme-aligned H2O molecule (van den Heuvel et al., 2000) to in-
troduce the hydroxyl group at C12b. Characteristically, the
hydroxylation event is accompanied by simultaneous ketore-
duction of the substrate (Cunane et al., 2000; Hopper and Cot-
trell, 2003; Freccero, 2004). Assisted byp electron delocalization
across the conjugated ring structure and specifically positioned
hydrogen donor in the enzyme active site, this leads to the C6
ketoreduction of the angucycline to yield 5.
Validation of the proposed mechanism by kinetic means
(Fraaije and van Berkel, 1997) is unfortunately not feasible due
to the number of interlinked enzymatic reactions and simulta-
neous presence of several intermediates in the PgaE/PgaM reac-
tion. For these reasons, verification of the model can most likely
be obtained only through structure/function studies currently in
progress in our laboratory. Previously, several different enzymes
involved in aromatic polyketide biosynthesis have been associ-
ated with atypical catalytic mechanisms (Sultana et al., 2004;
Jansson et al., 2005; Sciara et al., 2003). Characteristically, these
mechanisms employ the reactive chemical nature of the highly
conjugated polyaromatic substrate, which allows stabilization
through charge distribution over the intermediate ring structure
(Fetzner, 2002;Schneider, 2005). The resultspresentedhere sug-
gest that the reactionmechanismof PgaM follows this paradigm.Chemistry & Biology 15SIGNIFICANCE
Angucyclines are a well-defined group of aromatic polyketi-
des that have been shown to exhibit antimicrobial and
antitumor activities. Thus far, the biosynthesis of these com-
pounds has been studied mainly in vivo, where tailoring re-
actions in particular have raised wide interest due to their
potential use in combinatorial biosynthesis applications.
These studies have confirmed the curious existence of so-
called biosynthetic black boxes, defined to describe multi-
step cascades of nonseparable reactions.
In this in vitro study, we have isolated an early post-PKS
oxygenation cascade to gain insight into the catalytic steps
involved. PgaE and PgaM, which are representatives of fla-
voenzymes typically associated with these reactions, were
shown to catalyze multiple sequential reactions and to con-
vert UWM6 into a novel metabolite, gaudimycin C. The cata-
lytic sequence required close synchronization between the
successive steps to prevent intermediate degradation and
shunt product formation, and consisted of C12-hydroxyl-
ation followed by 12,7-quinone formation, C2,3-dehydration,
and C12b-hydroxylation, together with stereospecific C6
ketoreduction.
Another key finding of the study was that the C12b oxygen
of gaudimycin C derives from water. It demonstrates that
the oxygenase domain of PgaM catalyzes a novel type of hy-
droxylation reaction and that it is not a flavoprotein mono-
oxygenase, despite its significant sequence similarity to
knownmembers of the family. Furthermore, the results indi-
cate that the C12b-hydroxylation might be mechanistically
connected to C6 ketoreduction and that the reaction
cascade may proceed through a quinone methide interme-
diate., 157–166, February 2008 ª2008 Elsevier Ltd All rights reserved 163
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Expression Constructs
The plasmid, pBHBD, used for PgaE expression wasmodified from a commer-
cial vector, pBAD/HisB (Invitrogen), by shortening the region between N-termi-
nal polyhistidine tail and the multiple cloning site as described elsewhere (Kal-
lio et al., 2006). The entire 1476 bp coding region of PgaE was cloned from
pTOPO-pgaE (Palmu et al., 2007) into pBHBD as an EcoRI fragment. The
N-terminal end (319 bp BglII /BsiWI) was then replaced with a modified PgaE
PCR fragment to remove the original ATG start codon and extra 500 nucleotides
from the first cloning step. The amplification primers used to generate this frag-
ment were 50-AGATCTGACGCTGCCGTGATTGTCGT-30 and 50-ACTGTTCCA
GGTGGGTCTCGGTCAC-30. The final construct, pBHBD_PgaE, contained a 50
7-histidine coding region and two additional codons encoding for arginine and
serine preceding the PgaE ORF. The primary PgaM vector, pBHBD_PgaM,
was constructed accordingly. EcoRI fragment of pTOPO-pgaM (Palmu
et al., 2007) was subcloned into pBHBD, after which the PgaM N-terminal
end was replaced with a PCR product to remove the original start codon
and to add a BglII site. The PCR primers used to generate this fragment
were 50-AGTTTCCAGCCGAGGTTGACG-30 and 50-AGATCTAGCGAGGACCA
CACCGAGAC-30. A PgaM Streptomyces expression plasmid was constructed
by ligating the entire coding region and E. coli RBS from pBHBD_PgaM (Hin-
dIII/BamHI) into pIJE486 under the control of constitutively active ermEp pro-
moter (Ylihonko et al., 1996). Finally, a deletionmutant construct was designed
to produce the PgaM N-terminal oxygenase domain alone in E. coli as a His-
tag fusion. This was done by substituting the C-terminal half of PgaM (PstI/Hin-
dIII) in pBHBD_PgaM with a PCR fragment, which contains the end of PgaM
oxygenase domain followed by a termination codon, as described elsewhere
(Kallio et al., 2007). The primers used to generate the fragment were 50-
GGCCAGCCCTCAACCTCGG-30 and 50-TATAAGCTTTTAGAACCAGCGGCG
CAGC.
Expression and Purification of Proteins
PgaE was overexpressed in E. coli TOP10 strain as a 500 aa-long fusion pro-
tein containing the 490 aa native polypeptide and an N-terminal tag,
AHHHHHHHRS. The protein was produced in a 5 l fermentor batch culture
in 23 YT (yeast extract/tryptone) at room temperature (18 hr) and purified to
homogeneity in one nickel affinity chromatography step (5 ml HisTrap; Amer-
sham Biosciences). Purity was visualized by SDS PAGE gel electrophoresis
(Pharmacia PhastSystem), and the exact mass verified by protein mass spec-
trometry (TOF MS ES+). PgaE remained apparently stable for months when
stored at 20C (0.01 M Na3PO4 [pH 7.4], 0.25 M NaCl,  0.125 M imidazole,
and 50% glycerol). PgaMwas overexpressed in Streptomyces TK24 in parallel
250ml TSB batches in 1 l Erlenmayer flasks at 30C for 3 days. The protein was
purified in one-step nickel affinity chromatography (5ml HisTrap), carried out in
successive, consecutive loops to avoid protein precipitation induced by col-
umn overloading. Elution was followed by an immediate buffer exchange gel
filtration step to remove destabilizing imidazole in the buffer. PgaM remained
stable for months at 20C (0.01 M Na3PO4 [pH 7.4], 0.08 M NaCl, 25 mM im-
idazole, and 50% glycerol). PgaMox deletion mutant lacking the C-terminal re-
ductase domain was produced as N-terminal His-tag fusion and purified by
nickel affinity chromatography and gel filtration, as described elsewhere (Kallio
et al., 2007). Enzyme concentrations weremeasured by the Bradford dye bind-
ing method (Bradford, 1976).
Preparation of the Substrate
UWM6 (1)was produced inStreptomyces TK24/pMC6BD (Metsa¨-Ketela¨ et al.,
2003) with parallel 250 ml batches of E1 medium (Ylihonko et al., 1994) with
XAD-7 absorbent material (20 g/l) in a 7 day incubation at 30C/250 rpm. Pu-
rification was done by isopropanol gradient elution from XAD, H2O/chloroform
extractions to remove hydrophilic bulk impurities, and selective methanol sol-
ubilization to eliminate more hydrophobic compounds. Preparative RP-HPLC
was used as a polishing step (Merck-Hitachi HPLC system, LiChroCART 250-
10/RP-18 10 mmparticle size column, detection at 400 nm, 250 ml injection, 2.5
ml/min flow, gradient 15% acetonitrile + 0.1% HCOOH > acetonitrile + 0.1%
HCOOH, elution at 27 min). In vivo by-product 2 was extracted from the
preparate of 1 at this step.164 Chemistry & Biology 15, 157–166, February 2008 ª2008 ElsevieEnzyme Assays
PgaE in vitro activity was measured spectrophotometrically as a depletion of 1
at its absorption maximum at 406 nm. The reactions were carried out in 1 ml
volume of 100 mM potassium phosphate buffer [pH 7.5], containing a total
of 6% methanol, 0.2 mM NADPH, 50–75 nM PgaE, and 17.5 mM 1. Coupled
PgaE/PgaM reactions were prepared inmicrocentrifuge tubes (RT, gentle mix-
ing for 10–30 min) in equivalent conditions with threefold molar excess of
PgaM over PgaE. Reaction compounds were isolated in quantitative chloro-
form extractions, or by using analytical scale solid-phase extraction columns
(DSC-18; Supelco). Sampleswere solubilized/eluted inmethanol and analyzed
with HPLC (Shimadzu VP series HPLC chromatography system with a diode
array detector, Merck RP-18 column, isocratic 40% acetonitrile). Parallel reac-
tions were quantified and compared on the basis of peak areas at 406 or
428 nm, whereas degradation intermediates were detected at 230 nm.
18O Incorporation and Compartmentalized Reactions
Anaerobic reactions and conversions in 18O2 gas (Isotec; Sigma-Aldrich) were
carried out in a Thunberg cuvette, which allowed complete oxygen removal
with a combined vacuum (10min) and repeated N2 rinses before mixing the re-
action components. 18O water reactions were prepared in a total volume of
300 ml, in which 2:3 of the reaction buffer was replaced by H2O
18O isotope (Al-
drich Chemical Co.). Reactions were monitored spectrophotometrically and
products extracted quantitatively with acidic ethyl acetate for analysis by
HPLC-ESI-MS. The compartmentalized PgaE/PgaM reactions were carried
out in a 12 ml test tube with a cellulose acetate dialysis membrane (30 mm
outer diameter) with a 12–14 kDa MWCO to separate the enzymes; 1 was
added on the side of PgaM to demonstrate its ability to permeate through
the membrane. The reaction volumes were scaled up to 10 ml and incubation
times increased up to 60 min. Isolation and analysis of the compounds were
carried out as described above.
Preparation and Purification of Gaudimycin C for NMR
Chemoenzymatic conversion of 1 to 5 was carried out in 65 parallel 10 ml re-
actions in conditions equivalent to the analytical-scale PgaE/PgaM reactions.
Complete reactions were pooled and the compounds extracted with chloro-
form, and 5 was purified in two steps. First, a silica chromatography step
(Merck silica gel 60, 0.04–0.063 mm), with elution from hexane with increasing
chloroform (to 100%) and methanol gradient (to 2%). Second, preparative
HPLC (Phenomenex Luna phenyl-hexyl 100, 250 3 10 mm/10 mm column,
5%–100% acetonitrile gradient, detection at 420 nm, elution at around 50%
acetonitrile) with the same equipment used for purification of 1. The product,
monitored by HPLC, remained unchanged throughout the extraction steps
and in storage in methanol.
LC-MS and NMR Measurements
HPLC-ESI-MS analysis was performed with a Perkin-Elmer Sciex API 365 tri-
ple quadrupolemass spectrometer (Sciex, Toronto, Canada) equippedwith an
ion-spray interface. The HPLC system consisted of two Perkin-Elmer Series
200 micro pumps (Perkin-Elmer, Norwalk, CT) with a Series 200 autosampler
and 785A UV/VIS detector. Separation of compounds was carried out in the
same conditions and column as described for analytical HPLC. The 18O incor-
poration data presented in Table 1 were calculated from intensities of ion frag-
ments by dividing the signal of 18O ionization fragments with the corresponding
16O fragment signal in each run. NMR spectra were obtained with a Bruker
Avance DRX500 spectrometer. The NMRmeasurements weremade in chloro-
form-d1 at 233K and the
1H and 13C NMR chemical shifts were referenced to
tetramethylsilane. The number of scans for 1H, selective 1D-NOESY, COSY,
HSQC, and HMBC were 64, 256, 16, 64, and 160, respectively, due to the di-
lute sample. The decoupled 13C spectrum was run with 34,800 scans to reach
reasonable signal-to-noise ratio.
Analysis of Complex Formation
Analytical gel filtration was performed with the HPLC system described for
compound analysis, with a Tosoh Bioscience TSKgel SuperSW 3000 column
(4.63 300mm, 4 mm) in isocratic conditions (0.1MNa2SO4 in 0.1M phosphate
buffer [pH 7.6]) and 0.2 ml/min flow rate. The HMW gel filtration calibration kit
(Amersham Biosciences) was used as a molecular size ladder. Cross-linking
experiments between PgaE and PgaM preparates were carried out byr Ltd All rights reserved
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Chemoenzymatic Synthesis of Gaudimycin Cglutaraldehyde treatment of combined enzyme dilutions followed by SDS
PAGE analysis, as described elsewhere (Baykov et al., 1995).
SUPPLEMENTAL DATA
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